{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:51:26Z","timestamp":1794261086899,"version":"4.9.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T00:00:00Z","timestamp":1363737600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The incidence of oropharyngeal squamous cell carcinoma (OPSCC) has markedly increased over the last three decades due to newly found associations with human papillomavirus (HPV) infection. Primary radiotherapy (RT) is the treatment of choice for OPSCC at most centers, and over the last decade, the addition of concurrent chemotherapy has led to a significant improvement in survival, but at the cost of increased acute and late toxicity. Transoral robotic surgery (TORS) has emerged as a promising alternative treatment, with preliminary case series demonstrating encouraging oncologic, functional, and quality of life (QOL) outcomes. However, comparisons of TORS and RT in a non-randomized fashion are susceptible to bias. The goal of this randomized phase II study is to compare QOL, functional outcomes, toxicity profiles, and survival following primary RT (\u00b1 chemotherapy) vs. TORS (\u00b1 adjuvant [chemo] RT) in patients with OPSCC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods\/Design<\/jats:title>\n            <jats:p>The target patient population comprises OPSCC patients who would be unlikely to require chemotherapy post-resection: Tumor stage T1-T2 with likely negative margins at surgery; Nodal stage N0-2, \u22643\u2009cm in size, with no evidence of extranodal extension on imaging. Participants will be randomized in a 1:1 ratio between Arm 1 (RT\u2009\u00b1\u2009chemotherapy) and Arm 2 (TORS\u2009\u00b1\u2009adjuvant [chemo] RT). In Arm 1, patients with N0 disease will receive RT alone, whereas N1-2 patients will receive concurrent chemoradiation. In Arm 2, patients will undergo TORS along with selective neck dissections, which may be staged. Pathologic high-risk features will be used to determine the requirement for adjuvant radiotherapy +\/- chemotherapy. The primary endpoint is QOL score using the M.D. Anderson Dysphagia Inventory (MDADI), with secondary endpoints including survival, toxicity, other QOL outcomes, and swallowing function. A sample of 68 patients is required.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>This study, if successful, will provide a much-needed randomized comparison of the conventional strategy of primary RT vs. the novel strategy of primary TORS. The trial is designed to provide a definitive QOL comparison between the two arms, and to inform the design of an eventual phase III trial for survival outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01590355?term=NCT01590355&amp;rank=1\" ext-link-type=\"uri\">NCT01590355<\/jats:ext-link>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-13-133","type":"journal-article","created":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T11:14:23Z","timestamp":1363778063000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Early-stage squamous cell carcinoma of the oropharynx: Radiotherapy vs. Trans-Oral Robotic Surgery (ORATOR) \u2013 study protocol for a randomized phase II trial"],"prefix":"10.1186","volume":"13","author":[{"given":"Anthony C","family":"Nichols","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Alex","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Winquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varagur","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Danielle","family":"MacNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Scott","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Kuruvilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Corsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Odell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libni","family":"Eapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Theurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bret","family":"Wehrli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,20]]},"reference":[{"issue":"32","key":"3784_CR1","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","volume":"29","author":"AK Chaturvedi","year":"2011","unstructured":"Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W: Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011, 29 (32): 4294-4301. 10.1200\/JCO.2011.36.4596.","journal-title":"J Clin Oncol"},{"issue":"11","key":"3784_CR2","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1002\/cncr.10567","volume":"94","author":"JT Parsons","year":"2002","unstructured":"Parsons JT, Mendenhall WM, Stringer SP, Amdur RJ, Hinerman RW, Villaret DB, Moore-Higgs GJ, Greene BD, Speer TW, Cassisi NJ: Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer. 2002, 94 (11): 2967-2980. 10.1002\/cncr.10567.","journal-title":"Cancer"},{"issue":"12","key":"3784_CR3","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s00405-009-1109-2","volume":"266","author":"M Haigentz Jr","year":"2009","unstructured":"Haigentz M, Silver CE, Corry J, Genden EM, Takes RP, Rinaldo A, Ferlito A: Current trends in initial management of oropharyngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol. 2009, 266 (12): 1845-1855. 10.1007\/s00405-009-1109-2.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"3784_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"JP Pignon","year":"2009","unstructured":"Pignon JP, Le Maitre A, Maillard E, Bourhis J: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009, 92 (1): 4-14. 10.1016\/j.radonc.2009.04.014.","journal-title":"Radiother Oncol"},{"issue":"21","key":"3784_CR5","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1200\/JCO.2007.14.8841","volume":"26","author":"M Machtay","year":"2008","unstructured":"Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, Forastiere A, Ang KK: Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008, 26 (21): 3582-3589. 10.1200\/JCO.2007.14.8841.","journal-title":"J Clin Oncol"},{"key":"3784_CR6","doi-asserted-by":"publisher","first-page":"945162","DOI":"10.5402\/2012\/945162","volume":"2012","author":"SA Dowthwaite","year":"2012","unstructured":"Dowthwaite SA, Franklin JH, Palma DA, Fung K, Yoo J, Nichols AC: The role of transoral robotic surgery in the management of oropharyngeal cancer: a review of the literature. Isrn Oncology. 2012, 2012: 945162-","journal-title":"Isrn Oncology"},{"issue":"2","key":"3784_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/hed.21688","volume":"34","author":"FD Leonhardt","year":"2012","unstructured":"Leonhardt FD, Quon H, Abrahao M, O'malley BW, Weinstein GS: Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function. Head Neck. 2012, 34 (2): 146-154. 10.1002\/hed.21688.","journal-title":"Head Neck"},{"issue":"24","key":"3784_CR8","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1093\/jnci\/91.24.2081","volume":"91","author":"G Calais","year":"1999","unstructured":"Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Bertrand P: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999, 91 (24): 2081-2086. 10.1093\/jnci\/91.24.2081.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"3784_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ijrobp.2010.10.041","volume":"82","author":"J Setton","year":"2012","unstructured":"Setton J, Caria N, Romanyshyn J, Koutcher L, Wolden SL, Zelefsky MJ, Rowan N, Sherman EJ, Fury MG, Pfister DG: Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the memorial Sloan-Kettering cancer center experience. Int J Radiat Oncol Biol Phys. 2012, 82 (1): 291-298. 10.1016\/j.ijrobp.2010.10.041.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"3784_CR10","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1001\/archoto.2011.172","volume":"137","author":"CF Sinclair","year":"2011","unstructured":"Sinclair CF, Mccolloch NL, Carroll WR, Rosenthal EL, Desmond RA, Magnuson JS: Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2011, 137 (11): 1112-1116. 10.1001\/archoto.2011.172.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"3784_CR11","unstructured":"Bosco LF, Silliman RA, Thwin SS, Geiger AM, Buist DSM, Prout MN, Yood MU, Haque R, Wei F, Lash TL: A most stubborn bias: No adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol. In Press, Corrected Proof"},{"issue":"4","key":"3784_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/hed.21500","volume":"33","author":"MA Cohen","year":"2011","unstructured":"Cohen MA, Weinstein GS, O'malley BW, Feldman M, Quon H: Transoral robotic surgery and human papillomavirus status: oncologic results. Head Neck. 2011, 33 (4): 573-580. 10.1002\/hed.21500.","journal-title":"Head Neck"},{"key":"3784_CR13","unstructured":"Radiation Therapy Oncology Group: Active protocols. [http:\/\/www.rtog.org]"},{"key":"3784_CR14","doi-asserted-by":"crossref","unstructured":"Lawson G, Matar N, Remacle M, Jamart J, Bachy V: Transoral robotic surgery for the management of head and neck tumors: learning curve. Eur Arch Otorhinolaryngol. 268 (12): 1795-1801.","DOI":"10.1007\/s00405-011-1537-7"},{"key":"3784_CR15","unstructured":"Nccn Clinical Practice Guidelines: [http:\/\/www.nccn.org]"},{"issue":"2","key":"3784_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ijrobp.2007.10.015","volume":"71","author":"CT Liao","year":"2008","unstructured":"Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang SF, Cheng AJ: Does adjuvant radiation therapy improve outcomes in pT1-3N0 oral cavity cancer with tumor-free margins and perineural invasion?. Int J Radiat Oncol Biol Phys. 2008, 71 (2): 371-376. 10.1016\/j.ijrobp.2007.10.015.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"28","key":"3784_CR17","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.1200\/JCO.2005.01.149","volume":"23","author":"LV Rubinstein","year":"2005","unstructured":"Rubinstein LV, Korn EL, Freidlin B, Hunsberger S, Ivy SP, Smith MA: Design issues of randomized phase II trials and a proposal for phase II screening trials. J Clin Oncol. 2005, 23 (28): 7199-7206. 10.1200\/JCO.2005.01.149.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3784_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/cncr.22799","volume":"110","author":"J Ringash","year":"2007","unstructured":"Ringash J, O'sullivan B, Bezjak A, Redelmeier DA: Interpreting clinically significant changes in patient-reported outcomes. Cancer. 2007, 110 (1): 196-202. 10.1002\/cncr.22799.","journal-title":"Cancer"},{"key":"3784_CR19","volume-title":"Diffusion of innovations","author":"E Rogers","year":"2003","unstructured":"Rogers E: Diffusion of innovations. 2003, New York, USA: Free Press, 5","edition":"5"},{"issue":"9695","key":"3784_CR20","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/S0140-6736(09)61116-8","volume":"374","author":"P Mcculloch","year":"2009","unstructured":"Mcculloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC, Nicholl J, Aronson JK, Barkun JS, Blazeby JM: No surgical innovation without evaluation: the IDEAL recommendations. Lancet. 2009, 374 (9695): 1105-1112. 10.1016\/S0140-6736(09)61116-8.","journal-title":"Lancet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-133\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:50:43Z","timestamp":1630536643000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,20]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3784"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-133","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,20]]},"assertion":[{"value":"7 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"133"}}